Cargando…
Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
BACKGROUND: Drug-resistant tuberculosis remains a major public health threat complicating tuberculosis control programs globally. Data on rifampicin resistance (RR), which is a surrogate marker for multidrug resistance, are limited among Ethiopian tuberculosis patients. This study aimed to determine...
Autores principales: | Araya, Shambel, Negesso, Abebe Edao, Tamir, Zemenu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547769/ https://www.ncbi.nlm.nih.gov/pubmed/33116664 http://dx.doi.org/10.2147/IDR.S263023 |
Ejemplares similares
-
The Magnitude of Hematological Abnormalities Among COVID-19 Patients in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2021) -
Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia
por: Arega, Balew, et al.
Publicado: (2019) -
Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021
por: Diriba, Getu, et al.
Publicado: (2022) -
Thyroid Profile and Factors Associated with Hypothyroidism Among Multidrug-Resistant Tuberculosis Patients Attending Saint Peter’s Specialized Hospital Addis Ababa, Ethiopia
por: Biranu, Endalkchew, et al.
Publicado: (2021) -
Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia
por: Meaza, Abyot, et al.
Publicado: (2021)